932 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA http://www.zacks.com/stock/news/631469/endos-endp-bla-for-cellulite-treatment-accepted-by-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-631469 Nov 21, 2019 - The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks.
Teva Is Due For A Substantial Re-Rating https://seekingalpha.com/article/4308148-teva-due-substantial-re-rating?source=feed_tag_israel Nov 20, 2019 - Thanks to its debt offering, a heavily dilutive equity issuance has become very unlikely.The upsized offering also highlights that debt markets are not seeing a large bankruptcy risk.The only remainin
Teva Is Due For A Substantial Re-Rating https://seekingalpha.com/article/4308148-teva-is-due-for-substantial-re-rating?source=feed_tag_israel Nov 20, 2019 -
Teva, Bausch Could Be Next to File for Bankruptcy http://www.gurufocus.com/news/987459/teva-bausch-could-be-next-to-file-for-bankruptcy Nov 19, 2019 - Teva, Bausch Could Be Next to File for Bankruptcy, Stocks: AKAOQ,PTXTQ,TEVA,BHC,ENDP,AMRX,AKRX,AMAG,CLVS, release date:Nov 19, 2019
Teva prices upsized $2.1B debt offering https://seekingalpha.com/news/3520567-teva-prices-upsized-2_1b-debt-offering?source=feed_news_all Nov 19, 2019 -
Why It Is Time To Load Up On Teva Stock https://seekingalpha.com/article/4305975-time-load-teva-stock?source=feed_tag_israel Nov 12, 2019 - Investors responded favorably to Teva's third-quarter earnings report.Litigation risks dissipating.Strong pipeline, initial sales of new drugs, and more.
Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other http://feeds.benzinga.com/~r/benzinga/~3/03Y3GeJlftA/teva-vs-amneal-jpmorgan-sees-hope-for-one-decline-for-the-other Nov 12, 2019 -

It’s been a rough 2019 for some biotechs. Amneal Pharmaceuticals Inc (NYSE: AMRX) is down 81% year-to-date, while Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is down 41%.

Is Teva Pharmaceutical Industries Ltd. (TEVA) a Great Value Stock Right Now? http://www.zacks.com/stock/news/614175/is-teva-pharmaceutical-industries-ltd-teva-a-great-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-614175 Nov 11, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teva launches $1.5B debt offering https://seekingalpha.com/news/3517269-teva-launches-1_5b-debt-offering?source=feed_news_all Nov 08, 2019 - Aimed at rolling over three series of outstanding debt due in 2021, Teva Pharmaceutical Industries (TEVA +4.5%) launches a $1.5B private offering Euro-denominated Senior Notes.Pricing and terms have y
Teva (TEVA) Q3 Earnings Miss, Stock Up on Guidance Increase http://www.zacks.com/stock/news/610241/teva-teva-q3-earnings-miss-stock-up-on-guidance-increase?cid=CS-ZC-FT-analyst_blog|earnings_article-610241 Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.

Pages: 12345678...94

<<<Page 3>